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Short version of title: Robot-assisted surgery for the management of apical prolapse.  
 
Abstract  
Objective: Robot-assisted surgery is a recognized treatment for pelvic-organ prolapse. Many 
of the surgical subgroup outcomes for apical prolapse are reported together leading to a 
paucity of homogenous data.  
Design: Prospective observational cohort study (https://clinicaltrials.gov; identifier 
NCT01598467) assessing outcomes for homogeneous subgroups of robot-assisted apical 
prolapse surgery.   
Setting: Two European tertiary referral hospitals. 
Population: Consecutive patients undergoing robot-assisted sacrocolpopexy (RASC) and 
supracervical hysterectomy with sacrocervicopexy (RSHS).  
Methods: Anatomical cure (simplified Pelvic Organ Prolapse Quantification (sPOPQ) stage 
1,), subjective cure (symptoms of bulge) and quality of life (Pelvic Floor Impact 
Questionnaire [PFIQ-7]).  
Main Outcome measures: Primary outcome: anatomical and subjective cure. Secondary 
outcomes: surgical safety and intraoperative variables.  
Results: Total 305 patients included (RASC N=188, RSHS N=117). Twelve months follow-










This article is protected by copyright. All rights reserved. 
apical compartment occurred in 91% (RASC)and in 99% (RSHS). In all compartments, 
success percentages were 67% and 65% respectively. Most recurrences were anterior 
compartment (15.7% RASC [symptomatic 12.1%]; 22.9% RSHS [symptomatic 4.8%]). 
Symptoms of bulge improved from 97.4% to 17.4% (p<0.0005). PFIQ-7 scores improved 
from 76.7 ± 62.3 to 13.5 ± 31.1 (p<0.0005). Duration of surgery increased significantly in 
RSHS (183.1 ± 38.2 versus 145.3 ± 29.8 [p<0.0005]). Intraoperative complications and 
conversion rates were low (RASC: 5.3% and 4.3%; RSHS: 0.0% and 0.0%). Four severe 
postoperative complications occurred after RASC (2.1%) and one after RSHS (1.6%)  
Conclusion: This is the largest reported prospective cohort study on robot-assisted apical 
prolapse surgery. Both procedures are safe, with durable results.  
Funding: none. 
Keywords: pelvic organ prolapse, robot-assisted, sacral colpopexy, sacrocervicopexy, 
sacrocolpopexy 
 
Tweetable abstract:  
European bi-centre trial concludes that robot- assisted surgery is a viable approach to 




Over the last fifteen years the number of robot-assisted procedures performed for the 
treatment of female pelvic organ prolapse (POP) has increased. This is, in part due to the 
perceived simplification of complex laparoscopic manoeuvres and improved surgeon 
ergonomics.
[1, 2]
 Despite this increase, there is a paucity of scientific papers reporting on 
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Furthermore, there should be a concern regarding the heterogeneity of surgical subgroups and 
techniques used within the published literature
[3]
. In particular, most studies examining robot-
assisted surgery for apical prolapse tend to combine surgery to support the vault 
(sacrocolpopexy) with surgery to support the cervix in patients with prior subtotal 
hysterectomy (sacrocervicopexy) and surgery to support the uterus (sacrohysteropexy) 
together. This makes it impossible to define outcomes relevant to each surgical subgroup, 
which has implications for how women are counselled regarding the selection of surgical 
approach. A recent paper by Anglim et al
[4]
 reported on the factors influencing patient and 
surgeon decision-making regarding uterine preservation or hysterectomy in the management 
of apical prolapse. A factor was literature bias, the Cochrane review in 2016 stated that the 
level of published evidence was poor 
[5]
. Furthermore, randomised controlled studies 
comparing robotic and laparoscopic apical repair include a low number of patients and 
acknowledge a diversity of surgeon experience, which makes true assessment of outcomes 
very challenging
[6, 7]
. The difficulty in performing a randomised control trial (RCT) in robotic 
surgery was described in an editorial by Collins et al. They describe the negative effect of 
patient, surgeon and healthcare system bias on RCT and highlight the role of prospective 
cohort studies in robot-assisted surgery
[8]
. The strength of this prospective European bicentre 
cohort study was to address these issues, in particular, to provide results from homogeneous 
groups of procedures performed by robotically experienced surgeons. The main outcome 




The Prospective Assessment of Robotic Sacrocolpopexy: a European Bicentre Cohort 
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European hospitals performing robot-assisted apical repair for symptomatic POP. Patients 
were not involved in the development of this research. All consecutive patients undergoing 
RASC or robot-assisted laparoscopic supracervical hysterectomy with sacrocervicopexy 
(RSHS) between 2008-2016 in Cork University Maternity Hospital (Ireland), and Meander 
Medical Centre (The Netherlands) were included. Both hospitals provide tertiary level care 
for patients with POP. Preoperative counselling on alternative treatments and the risks and 
benefits of the procedure were discussed. Patients were consented accordingly. Vaginal 
prolapse was defined using the simplified Pelvic Organ Prolapse Quantification (sPOPQ)
[9]
. 
sPOPQ describes four vaginal landmarks (A: anterior vaginal wall; B: posterior vaginal wall; 
C: vaginal cuff/cervix; D: fornix posterior)
[9, 10]
. sPOPQ stage 1 describes either no prolapse 
or a minimal prolapse (>1 cm above the hymnal remnants). In stage 2, the given point 
descends 1 cm above to 1cm below the hymnal remnants. Stage 3 describes a prolapse which 
descends more than 1 cm beyond the hymenal remnants, but does not represent stage 4, 
which includes complete vaginal vault eversion or complete procidentia uteri. Stage 0 does 
not exist by definition of the sPOPQ system. Inclusion criteria were: symptomatic vaginal or 
uterine prolapse with sPOPQ stage ≥ 2. Exclusion criteria were: age < 18 year, poor health 
status with inability to undergo general anaesthesia, ≥ 3 previous laparotomies, planned 
pregnancy and patients with a known pelvic malignancy. In patients with their uterus still 
present, preoperative work-up for endometrial cancer or sarcoma was performed. An 
ultrasound and preoperative cervical cytology was performed in all patients. 
The primary outcome measurement was anatomical cure, described as any sPOPQ point <2. 
Patients were followed-up routinely with vaginal examination at six weeks and twelve 
months postoperatively, or at the onset of new symptoms. Failure was defined as any 
postoperative sPOPQ point stage ≥ 2 or retreatment. Recurrences were divided in 
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considered symptomatic when there were symptoms of bulge (sensation of, and/or seeing 
vaginal bulge) and/or retreatment (any POP reoperation (planned) or insertion of a vaginal 
pessary). Patients received a questionnaire preoperatively and at follow-up (at one and at five 
years). The questionnaires included questions regarding sensation of prolapse, quality of life 
(QoL) based on the Pelvic Floor Impact Questionnaire (PFIQ-7)
[11]
 urinary and defecation 
symptoms, presence of dyspareunia, and use of medication. The PFIQ-7 combines three QoL 
scales: Urinary Impact Questionnaire, Colorectal-Anal Impact questionnaire and Pelvic 
Organ Prolapse Impact Questionnaire. Higher scores indicate a higher impact of symptoms 
on daily life (range 0-300). The questionnaire was discussed during the one-year 
postoperative visit or returned by post if clinical consultation was not possible. If no vaginal 
examination (sPOPQ) was available and no questionnaire at the 12-month time point, 
patients were considered lost to follow-up.  
The secondary outcomes measured were safety of the procedure and intraoperative variables. 
‘Total surgery time’ was defined as the time from first incision until the final suture was tied. 
Postoperative pain scores were measured on the first morning after surgery using the Visual 
Analogue Scale (VAS; range 0-10).
 
Intra-operative complications were scored using the 
following definition: ‘Any deviation from the ideal intraoperative course occurring between 
skin incision and skin closure, including both surgery or anaesthesia-related 
complications’
[12]
. A deviation from the planned intervention to manage unexpected 
intraoperative findings was not regarded as complication (e.g. severe intra-abdominal 
adhesions). In case of a conversion, an open abdominal sacrocolpopexy was performed, 
unless otherwise specified. Postoperative complications occurring within six weeks were 
defined as ‘early complications’ and scored following the Clavien-Dindo Classification
[13].
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are no agreed standardised core outcome sets available for urogynaecology therefore specific 
recognised outcome measures were utilised in this study.  
The surgical technique used for the RASC group is similar to that described by Clifton et 
al
[14]
. Surgeries were performed by five gynaecologists. All surgeries were performed with 
the assistance of the da Vinci robot (Intuitive Surgical, Inc., Sunnyvale, CA, USA) and 
suspension was performed with type 1 polypropylene mesh (Prolene® [Ethicon Inc.] or 
Restorelle® [Coloplast]). Either a preformed Y shaped mesh was used, or two separate 
meshes, which were configured into a ‘Y’ shape intracorporeally. The mesh was distally 
attached using non-absorbable sutures (Ethibond® or Gore-Tex®). Proximal anchoring of the 
mesh to the sacral promontory was performed with titanium tacks (Autosuture Protack 5mm, 
Covidien, USA) or non-absorbable sutures (Gore-tex®). The peritoneum was approximated 
to cover the mesh completely using a 23 cm V-Loc suture (Covidien, Mansfield, MA, USA). 
The RSHS group had a supracervical hysterectomy performed prior to attaching the mesh to 
the anterior and posterior aspect of the cervix using mesh and sutures as for the RASC group.  
Additional procedures were performed when clinically indicated. Due to recent scientific data 
on the pathophysiology of ovarian malignancy and spill in case of sarcoma, concomitant 
salpingectomy and “in bag” morcellation was performed starting from the year 2015
[15, 16]
.  
This study was in accordance to the ethical regulations of the Clinical Research Ethics 
Committee (CREC, University College Cork, Ireland) and the National Central Committee 
on Research Involving Human Subjects (CCMO, The Netherlands). No funding was received 
to conduct this study. Statistical analysis was performed using SPSS v. 22.0 (IBM Corp., 
Armonk, NY, USA). Data were presented as mean ± standard deviation (SD) and median and 
interquartile range (IQR) for normally and non-normally distributed continues values 
respectively. In case of sPOPQ values with only 4 stages, data were presented as mean ± SD. 
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T-test, Mann-Whitney U test and Chi-Square Test or Fisher’s Exact Test were used to 




In total 305 patients were included. One hundred and eighty-eight patients underwent RASC 
and 117 patients RSHS (Figure 1). One hysteropexy was performed instead of supracervical 
hysterectomy due to severe adhesions (0.9%). The baseline characteristics of patients are 
depicted in Table 1. When no hysterectomy was performed previously, patients were 
significantly younger (59.9 versus 63.1 [p= 0.009]) and had on average a more severe pre-
operative prolapse of the anterior compartment than patients undergoing RASC (mean S-POP 
point A stage 2.9 versus 2.5 [p<0.0005]). The median follow-up time was 12.6 and 14.8 
months for RASC and RSHS, respectively. Ninety-five percentage of all patients were seen 
six weeks postoperatively and 83% 12 months postoperatively. Number of follow-up per 




For both types of surgery, the mean values for all the sPOPQ anatomical landmarks improved 
significantly (RASC p<0.0005; RSHS p<0.0005). The apical compartment success rate was 
91.4% for RASC and 99.0% for RSHS. All compartments were associated with a success rate 
of 67.1% for RASC and 64.8% for RSHS. However, when solely looking at symptomatic 
recurrences, the success rates increased to 73.6% and 88.6% respectively. Complaints of 
symptoms of bulge diminished significantly after surgery: preoperatively 297 of 305 patients 
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[p<0.0005]). QoL improved significantly: mean preoperative PFIQ-7 scores were 76.7 ± 62.3 
and diminished postoperatively to 13.5 ± 31.1 [p<0.0005]. Further details of anatomical 
results are listed below in table 2. 
 
Robot-assisted sacrocolpopexy (n=188) 
Six weeks postoperative 88.1% of patients showed no prolapse (sPOPQ=1 for all anatomical 
landmarks). There were two apical recurrences, both stage 2 (1.1%). After 12 months, 94 of 
140 examined patients (67.1%) showed no objective recurrence and 103 patients (73.6%) had 
no symptomatic recurrence [Table 2]. One hundred and twenty-eight patients had no 
recurrence in the apical compartment (91.4%). Of the 12 patients with apical recurrence, 
more than half were stage 2 (Stage 2: N=7 (5.0%); stage 3: N=4 (2.9%); stage 4: N=1 (0.7%). 
When assessing all three compartments an isolated anterior wall prolapse occurred most 
frequently in 22 patients (15.7%) (sPOPQ stage 2: N=10 (7.1%); stage 3: N=9 (6.4%); stage 
4: N=1 (0.7%)); unreported stage at repeat surgery N=2 (1.4%)). Assessing recurrences, 
isolated cystoceles accounted for 47.8% of these; nine recurrences were asymptomatic 
(19.6%). Approximately a quarter (22.9%) of the postoperative patients required a prolapse-
related reoperation, mostly consisting of vaginal repair (Table 3). Eight out of 140 patients 
(5.7%) reported symptoms of bulge, but had no objective prolapse during physical 
examination. Compared to RSHS, there was no difference in the objective success 
percentage. However, a significant difference was found in the number of patients with a 
symptomatic recurrence (73.6% versus 88.6%; p=0.006). In RASC, 184/188 patients (97.9%) 
reported preoperative symptoms of bulge versus 26/144 (18.1%) postoperatively (p<0.0005). 
PFIQ-7 scores improved significantly: preoperative 89.7 ± 64.1 versus postoperative 14.6 ± 
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Robot-assisted supracervical hysterectomy with sacrocervicopexy (n=117) 
After six weeks, no recurrences were found in the apical compartment. After one year, one 
patient had a recurrent prolapse of the apical compartment (Stage 4; 1.0% [Table 2]). A redo-
cervicopexy was performed, which revealed a laxity in the mesh, it was shortened, with no 
recurrence afterwards. Across all compartments, there were 37 recurrences (35.2%) of which 
12 were symptomatic (11.4%). Twenty-four recurrences were anterior compartment 
prolapses, mostly being stage 2 (N=18) and asymptomatic. In 3.7% of patients prolapse 
related retreatment was necessary, including the redo-cervicopexy mentioned above. One 
hundred and thirteen of 117 patients (96.6%) reported symptoms of bulge prior to surgery 
versus 18 of 109 patients (16.5%) after surgery (p<0.0005). A significant improvement in 
QoL scores was found: 53.7 ± 52.0 versus 12.5 ± 30.0 (p=0.002). In one of the postoperative 
pathology examinations, one patient with endometrial cancer was identified. Further 




Intra operative complications 
In total, ten intraoperative complications (3.3%) were identified in both groups. All of these 
complications occurred in the RASC group, which was significantly higher in comparison to 
RSHS [Table 3; 5.3 % versus 0.0%; p=0.008]. The most common complication was 
cystotomy (6/10), of which two resulted in conversion. There was one haemorrhage from the 
presacral venous plexus due to the use of a metal retractor for holding small bowel out of the 
operative field. There were eight conversions, 4 due to intraoperative complications, of which 
one was due to excessive adhesions. Three were the result of atypical anatomy of the sacral 
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sacral promontory due to significant presacral fat). Furthermore, in two cases, ventilation 
problems in steep Trendelenburg position prior to incision occurred: one surgery was 
abandoned and in the other an open sacrocolpopexy was performed instead.  
   
Intraoperative data 
The intraoperative variables are listed in Table 3. Concomitant procedures such as TVT-O, 
salpingo-ophorectomy and anterior colporrhaphy were significantly more frequently 
performed in RSHS than RASC (9.4% versus 2.1% [p=0.004], 8.5% versus 0.5% [p<0.0005], 
11.1% versus 3.2% [0=0.005]). Duration of surgery was the lowest in the RASC group 
(145.3 minutes ± 29.8). Performance of supracervical hysterectomy, made the surgery 
significantly longer [mean difference 38 minutes]. Median blood loss was low for both 
surgeries: 25-50 millilitres [IQR 10-100]).  
 
Early postoperative complications 
There were 22 (7.2%) early postoperative complications, 16 (8.5%) after RASC and 6 (5.1%) 
after RSHS. The majority were minor stage 1-2 complications requiring small interventions. 
Five complications were severe (Clavien Dindo Classification ≥3; Table 3). One ischemic 
CVA occurred after RSHS (0.9%), with full recovery after therapy with anticoagulants. The 
remaining severe postoperative complications were after RASC (2.1%): one incisional hernia 
needing surgical correction, one haemorrhagic CVA resulting in subdural hematomas 
requiring surgery, one bowel perforation requiring colostomy and ICU admission.  
 
Late complications 
There were four mesh-related complications after RASC (2.1%): three vaginal mesh 










This article is protected by copyright. All rights reserved. 
patients needed complete surgical mesh removal of the mesh (1.1%). Four late complications 
occurred after RSHS (3.4%): one vaginal mesh exposure, one exposure of a concomitant 
inserted TVT-O and two incisional port herniations, one needing surgical correction. In total, 
with early postoperative complications included, 1.0% of patients (3/305) were identified 




The results from this large bicentre prospective cohort study demonstrates that the robotic 
approach is an effective and reproducible technique with excellent results associated with the 
apical compartment (91-99%). Recurrences were mostly located in the anterior compartment: 
15.7% after RASC (symptomatic 12.1%) and 22.9% after RSHS (symptomatic 4.8%). 
Quality of life and subjective symptoms of bulge improved significantly. Intra- and 
postoperative complications were low. Mean duration of surgery was 145 minutes for RASC 
and 183 for RSHS. 
  
Strengths and limitations 
Strengths of this study include the size of study group, the prospective design and high recall 
and duration of follow up. Further strengths were the avoidance of heterogeneity across both 
the surgery subgroups and the surgical technique used as well as the experience of surgeons 
involved. The main goal of this study was to provide accurate numbers for each procedure, as 
differentiation between these two subtypes of surgery in other studies is often not clear. 
Choice for RASC/RSHS was dependent on the presence of the uterus. As there were 
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The results regarding the apical compartment compare favourably with results from a 
previously reported systematic review
[3]
. The systematic review reported success rates for all 
compartments from 84% to 100%, which are higher than the success rates of 65%-67% in 
this study. The systematic review, included papers with low numbers of patients, 
heterogeneous surgeries, different definitions and variable follow-up periods, most were 
retrospective by design. Only one study by Culligan et al. prospectively presented one-year 
anatomical data on more than 100 robotic cases (N=150; sPOPQ exam N=143)
[16]
. While 
their definition of success, was comparable to ours, they reported on a heterogenous group of 
sacrocolpopexy and sacrocervicopexy. Approximately 80% of their group required a 
concomitant supracervical hysterectomy, which affects the surgical variables. They also had a 
much higher rate of concomitant anti-incontinence surgery (81%) than our two groups 
combined (5%). Of note, most of their recurrences were seen in the anterior compartment, 
similar to our findings. When solely looking at symptomatic recurrences occurring for all 
compartments, we found a 74% and 89% success rate for RASC and RSHS respectively. 
Nygaard et al.
[17]
 performed a large systematic review assessing abdominal sacrocolpopexy, 
follow-up ranged from 6 months to 3 years and showed an apical success rate of 78-100%. 
Success rates in all compartments varied from 58-100%, showing that women are at risk for 
postoperative prolapse in other compartments.  
Historically the treatment of anterior wall prolapse is problematic 
[18]
, and as our study 
illustrates it is similar post both RASC and RSHS. Placing the mesh as distal as possible on 
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huge difference in the technique used to anchor the mesh to the anterior vaginal wall between 





 described 79 women undergoing LSC, who considered themselves postoperatively 
cured or improved with no reoperation. After three years, 62% showed recurrence in the 
anterior compartment. Furthermore it highlighted that for every millimetre that the mesh was 
located further from the bladder neck (on Valsalva), the probability of a recurrent cystocele 
increases by 6-7%. Placing the mesh as close as possible to the bladder neck may improve the 
recurrence rate and the robotic system should facilitate this difficult and challenging 
dissection due to the improved freedom of movement and better suturing skills. However, as 
it might also increase complications rates, further research is necessary to confirm these 
theories.  
Postoperatively a higher percentage of recurrent cystocele was seen after RSHS, which could 
possibly be explained by the higher sPOPQ stage A preoperatively, this is associated with 
higher risk of recurrence
[21]
. However, comparisons between the two types of surgeries must 
be analysed carefully, since this study was not set up as a randomised controlled trial. 
Prendergast et al.
[22]
 conducted a study where just RSHS was included. The cure rate after 
one year (stage 1, using the standard POPQ assessment) was 72%. We found a success rate of 
65%, again, mostly affected by recurrent anterior wall prolapses, many being stage 2 and not 
symptomatic. When scoring solely symptomatic recurrences, success percentage raised to 
89% for RSHS. The clinical relevance of asymptomatic prolapse is unclear. Many definitions 
to describe success after POP repair have been used
[23]
. The hymen appears to be an 
important cut-off point in the occurrence of symptoms, which would be in line with our cut-
off point sPOPQ stage 2 or higher. Repeat surgery, in case of recurrence, were higher after 
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Significantly more intraoperative complications appeared in the RASC group. A history of 
previous hysterectomy, scar tissue and adhesions can complicate the RASC procedure, 
resulting possibly in more complications. Intraoperative blood loss, hospital stay and 
postoperative pain scores were low overall. Duration of surgery time was prolonged when 
adding a supracervical hysterectomy. Two RCT’s on RASC, reported procedure and total 
surgery time: respectively 227 ± 47 and 265 ± 50 minutes (N=35, all post hysterectomy 
patients), 202.8 ± 46.1 and 246.5 ± 51.3 minutes (N=40, concomitant hysterectomy N=25)
[6]
. 
Surgeons were required to have performed at least 10 procedures of RASC before study 
participation. Mean surgery time in our study is shorter, probably due to the larger number of 




Based on the low percentage of severe early and late postoperative complications, both 
procedures can be classified as safe. In RSHS, one patient with endometrial cancer was 
identified postoperatively. Proper preoperative work-up should be performed for those 
patients with a uterus. Since the FDA suggested in-bag morcellation in their statement in 
2014
[25]
, we started in bag morcellation to avoid the risk of morcellating a possible 
malignancy intra-abdominally. Postoperative pain scores were low for both procedures. 
Hospital stay was significantly shorter in RASC than RSHS, which could possibly be 
explained by different postoperative hospital regimes.  
 
Strengths of this study include the size of study group, the prospective design and high recall 
and duration of follow up. Further strengths were the avoidance of heterogeneity across both 
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This study provides answers to the questions- 1) When I am a competent robotic surgeon how 
long on average should it take to perform either a sacrcolpopexy or sacrocervicopexy. 2) 
When counselling patients regarding success rates for robot-assisted apical prolapse surgery 
what are the figures for each subgroup? 3) Are each of the robot-assisted surgical procedures 
for apical prolapse safe for my patients? 
 
Conclusion 
This large prospective cohort study shows that robot-assisted apical repair surgery gives 
durable anatomical results. Apical success rates were 91% and 99% for RASC and RSHS 
respectively. Postoperative anterior wall recurrences can occur and patients should be 
counselled accordingly. Both procedures are safe and, when performed regularly, performed 
within accessible time ranges.  
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Figures and Table legends 
 
Figure 1. Flow chart for included patients follow-up 
Time to follow-up is presented as median [IQR]. 
Abbreviations: FU: follow up. IQR: interquartile range. Mo: months. N: number. RASC: robot-assisted 
sacrocolpopexy. RSHS: robot-assisted supracervical hysterectomy with sacrocervicopexy. sPOPQ: number of 
patients with a sPOPQ examination. QNR: questionnaire.  
1
. One patient with a history of laparoscopic sacrocolpopexy. 
2
. Two patients with a history of ventral mesh 
rectopexy. 
3
. One hysteropexy due to adhesions. 
4
. Patients had no complaints and therefore refused 
consultation. 
5
. Due to natural causes.  
Table 1. Baseline characteristics and follow-up data.  
 
Abbreviations: BMI: Body-Mass Index. Inc: incontinence. N/A: not applicable. POP: pelvic organ prolapse. 
Prev: previous. RASC: robot-assisted sacrocolpopexy. RSCR: robot-assisted sacrocolporectopexy. RSHS: 
robot-assisted supracervical hysterectomy with sacrocervicopexy. RSSCR: robot-assisted supracervical 
hysterectomy with sacrocervicorectopexy. S-POP: simplified pelvic organ prolapse quantification.  
a
Comparing RASC with RSHS 
b
Excluding POP surgery. 
c
Includes laparotomy, laparoscopic and supracervical 
hysterectomy. 
d
Due to missing data, percentages cannot be calculated from the table. 
d
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Table 2. Recurrences and retreatments.  
Data presented as number (%) or mean values. Chi Squared Test was used to compare RASC with RSHS unless 
otherwise specified.  
Abbreviations: AC: anterior colporrhaphy. ACNES: anterior cutaneous nerve entrapment syndrome. compart.: 
compartment(s) N: number. PC: posterior colporrhaphy. RASC: robot-assisted sacrocolpopexy. RSCR: robot-
assisted sacrocolporectopexy. RSHS: robot-assisted supracervical hysterectomy with sacrocervicopexy. SC: 




Fishers’ Exact Test instead of Chi Square Test (expected count <5) 
c
Compared to pre-operative 
mean values in Table 1 using Paired Sample T-Test. 
 d
Of these 33 procedures 22 used transvaginal mesh 
e
One 
procedure was combined with perineorrhaphy 
f
One cervical amputation 
g
Before surgery, patient used a pessary. 
Peroperative the mesh was too loose and shortened 
h
Includes one colpocleisis 
i
Includes one discitis in which the 
mesh was removed at laparotomy.  
j
Removal of mesh exposure in outpatient clinic. 
 
 
Table 3. Intra-operative variables, hospital stay, pain scores and postoperative complications.  
Data presented as number (%), unless otherwise specified.  
Abbreviations: IQR: interquartile range. N/A: not applicable. RASC: robot-assisted 
sacrocolpopexy. RSHS: robot-assisted supracervical hysterectomy with 
sacrocervicopexy. TVT: Tension-free vaginal tape.  
a
Fishers’ Exact Test instead of Chi Squared Test (expected count <5) 
b
Conversion to 
laparotomy as first step to stop the bleeding; secondly an anterior colporrhaphy was 
performed 
c
Includes one conversion to sacrospinal fixation with anterior/posterior 
colporrhaphy 
d
More than one concomitant surgery in one patient was possible: scores 
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Characteristics  All patients RASC RSHS p-value
a 
     
Age (y), mean ± SD  61.8 ± 9.8 63.1 ± 8.7 59.9 ± 11.2 0.009 
     
BMI (kg/m
2














Postmenopausal, N (%) 274 (89.5) 186 (98.9) 88 (75.2) <0.0005 
     
Prev. intra-abd. surgery
b
, N (%) 99 (32.5)
 
56 (29.8) 43 (36.8) 0.207 
     
Prev. POP/incontinence. surgery, 
N (%) 
167 (54.8) 147 (78.2) 20 (17.1) <0.0005 
     

















     
Diabetes mellitus, N (%) 21 (6.9) 10 (5.3) 11 (9.4) 0.171 
     
Smoking
d
, N (%) 
 
42 (15.0) 25 (15.3) 17 (14.5) 0.337 
     
sPOPQ, mean ± SD  
         Stage A 2.6 ± 1.0 2.5 ± 1.0 2.9 ± 1.0 <0.0005 
         Stage B 2.1 ± 1.1 2.1 ± 1.1 2.0 ± 1.2 0.718 
         Stage C 3.1 ± 0.9 3.1 ± 0.8 3.0 ± 0.9 0.410 
         Stage D 2.6 ± 1.2 No uterus 2.2 ± 1.4 N/A 
     
Symptoms of bulge, N (%) 297 (97.4) 184 (97.9) 113 (96.6) 0.488
d
 
     
Abbreviations: BMI: Body-Mass Index. N/A: not applicable. POP: pelvic organ prolapse. Prev: previous. RASC: robot-assisted 
sacrocolpopexy. RSCR: robot-assisted sacrocolporectopexy. RSHS: robot-assisted supracervical hysterectomy with sacrocervicopexy. 
RSSCR: robot-assisted supracervical hysterectomy with sacrocervicorectopexy. sPOPQ: simplified pelvic organ prolapse quantification.  
aComparing RASC with RSHS bExcluding POP surgery. cIncludes open, laparoscopic and supracervical hysterectomy. dDue to missing 
data, percentages cannot be calculated from the table. dFishers’ exact test. 
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6 weeks S-POP exam N=177 N=114  
    
Success 156 (88.1) 97 (85.1) 0.463 




  3 (1.7) 0 (0.0) 0.282
b 
    
12 months S-POP exam N=140 N=105  
    
sPOPQ A 1.4 1.4 <0.0005
c 
sPOPQ B 1.2 1.2 <0.0005
c 






    
Success 94 (67.1) 68 (64.8) 0.680 
Success + asymptomatic recurrence.  
 
103 (73.6) 93 (88.6) 0.006 
    
Recurrence anterior compartment.  






Recurrence posterior compartment. 







Recurrence apical compartment 







Recurrence multiple compartments including 
the apical compartment 
Symptomatic recurrence multiple 









Recurrence multiple compartments excluding 
the apical compartment 
Symptomatic recurrence multiple 
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Retreatments N=144 N=109  
    
Prolapse related  
 
- Anterior vaginal repair 
- Posterior vaginal repair 
- Anterior and posterior vaginal repair 
- Vaginal Pessary 





























    
Complication related 
 
- Remove (part) mesh 
- ACNES 
















    
Data presented as number (%) or mean values. Chi Squared Test was used to compare RASC with RSHS unless otherwise specified.  
Abbreviations: AC: anterior colporrhaphy. ACNES: anterior cutaneous nerve entrapment syndrome. N: number. PC: posterior 
colporrhaphy. RASC: robot-assisted sacrocolpopexy. RSCR: robot-assisted sacrocolporectopexy. RSHS: robot-assisted supracervical 
hysterectomy with sacrocervicopexy. SC: sacrocolpopexy. TVT-O: transvaginal tape.  
aAll pessary bFishers’ Exact Test instead of Chi Square Test (expected count <5) cCompared to pre-operative mean values in Table 1 using 
Paired Sample T-Test.  dOf these 33 procedures 22 used transvaginal mesh eOne procedure was combined with perineorrhaphy fOne cervical 
amputation gBefore surgery, patient used a pessary. Intraoperatively the mesh was too loose and shortened hIncludes one colpocleisis 
iIncludes one discitis in which the mesh was removed at laparotomy. jRemoval of mesh exposure in outpatient clinic.  
    



















    
Intraoperative complications  
    - Bladder injury 
    - Bladder injury resulting in conversion 
    - Conversion due to bleeding  
    - Vaginal injury 





















    
Intraoperative conversions 
    - Intraoperative complication 
    - Adhesions 













    
Concomitant surgery
d 
     - TVT 
     - Adnexal (single/bilateral)  
     - Anterior colporrhaphy 
     - Posterior colporrhaphy 






















    
Salpingectomy 18 (9.6) 38 (32.5) <0.0005 
    
Blood loss in millimeters, median (IQR) 25 (10-50) 50 (10-100) 0.007 
    
Total surgery time, mean ± SD 145.3 ± 29.8 183.1 ± 38.2 <0.0005 
    
Hospital stay nights, median (IQR) 1.0 (1-2) 2.0 (1-3) <0.0005 
    
VAS, median (IQR) 2.0 (1-3) 2.5 (2-4) 0.305 
    
Early postoperative complications 
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     Grade 2 
     Grade 3 
     Grade 4 









Late complications 4/144 (2.8) 4/109 (3.7) 0.472 
    
Data presented as number (%), unless otherwise specified.  
Abbreviations: IQR: interquartile range. N/A: not applicable. RASC: robot-assisted sacrocolpopexy. RSHS: robot-assisted supracervical hysterectomy with 
sacrocervicopexy. TVT: Tension-free vaginal tape.  
aFishers’ Exact Test instead of Chi Squared Test (expected count <5) bConversion to laparotomy as first step to stop the bleeding; secondly an anterior 
colporrhaphy was performed cIncludes one conversion to sacrospinal fixation with anterior/posterior colporrhaphy dMore than one concomitant surgery in 
one patient was possible: scores do not add up.  
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